| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research | Officer Level 14 | EVP, Research +1 more
1 company
Eric Swayze is EVP Research at IONS. From January 2020 to October 2026, the filings on record show 0 open-market purchases and 24 sales. Eric Swayze's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $16K at current prices.
Historically, Eric Swayze's trades have earned a middling insider score of 67/100 across 24 rated trades. Over a 12-month horizon, 63.2% of those trades were profitable, with an average 12-month return of -5.1%.
The IONS filings lean toward selling, a net 175,425 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2022 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 460 | $44.55 | $20,493.00 | -2.3% | -13.7% | -6.9% | |
| Aug 5, 2022 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1 | $45.20 | $45.20 | - | -2.6% | -13.0% | |
| Apr 21, 2022 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 378 | $44.15 | $16,688.70 | -1.8% | -9.3% | -14.1% | |
| Jan 5, 2021 | IONS Ionis Pharmaceuticals Inc | EVP, Research | Sell | 195 | $55.99 | $10,918.05 | -3.7% | - | - |